Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Short term Debt (2022 - 2025)

Historic Short term Debt for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $6.9 million.

  • PAVmed's Short term Debt changed N/A to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year change of. This contributed to the annual value of $29.1 million for FY2024, which is 3416.29% down from last year.
  • As of Q3 2025, PAVmed's Short term Debt stood at $6.9 million.
  • PAVmed's Short term Debt's 5-year high stood at $45.5 million during Q1 2024, with a 5-year trough of $6.6 million in Q1 2025.
  • For the 4-year period, PAVmed's Short term Debt averaged around $30.3 million, with its median value being $34.6 million (2022).
  • Its Short term Debt has fluctuated over the past 5 years, first surged by 4572.88% in 2023, then plummeted by 8550.72% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Short term Debt stood at $33.6 million in 2022, then skyrocketed by 31.35% to $44.2 million in 2023, then tumbled by 34.16% to $29.1 million in 2024, then crashed by 76.29% to $6.9 million in 2025.
  • Its last three reported values are $6.9 million in Q3 2025, $6.8 million for Q2 2025, and $6.6 million during Q1 2025.